From March 24 to 29, the 11st Health Industry Ecological Platform (PHCF) was grandly held in Huzhou, Zhejiang Province. The conference brought together tens of thousands of industry professionals who witnessed the announcement of multiple authoritative industry awards. Among them, JumpCan Pharmaceutical's star products — Pudilan Xiaoyan Oral Liquid and Xiao'er Chiqiao Qingre Granules (Tonpei) — both won the title of "2025–2026 Best-Selling Products in China's Pharmaceutical Retail Market," with their brand strength in the retail market receiving renewed recognition.

 

The Health Industry Ecological Platform is one of China's largest and most influential industry events in the health products trading field. This edition, themed around "Best-Selling Products," focused on the pharmaceutical retail sector — covering prescription drugs, innovative drugs, medical devices, and the silver economy increment track — attracting over 9,000 terminal procurement parties including national and district/county top-100 pharmaceutical chains, TCM clinics, and private-domain e-commerce platforms, with total participation exceeding 50,000, jointly driving high-quality development in the retail industry.

 

 

2025–2026 Best-Selling Products in China's Pharmaceutical Retail Market

 

To set industry benchmarks and help companies precisely address diverse health needs, the conference organizing committee selected a batch of health products with strong terminal sales or development potential from across the country for commendation and showcase. Using data quantification as the basis, a scientific data model was applied to comprehensively evaluate health products, with product strength, product growth potential, and product accessibility as the core indicators, providing guidance for terminal product selection and precise navigation for supply-retail collaboration.

 

Leveraging years of deep strategic deployment in the pharmaceutical retail market, Pudilan Xiaoyan Oral Liquid and Xiao'er Chiqiao Qingre Granules (Tonpei) — with advantages including high market share, high consumer loyalty, strong product growth potential, and high patient accessibility — won broad recognition from consumers and pharmacy staff, both being named "2025–2026 Best-Selling Products in China's Pharmaceutical Retail Marke," encouraging retail terminals to focus on consumer needs for precise product selection and promoting high-quality health products for the benefit of the general public.

 

 

 

In recent years, as China's domestic pharmaceutical retail market has continuously developed toward greater convenience, diversification, and quality, JumpCan Pharmaceutical has actively optimized its product portfolio, strengthened brand building, and expanded online and offline channel resources in multiple dimensions to meet diverse market demands. Pudilan Xiaoyan Oral Liquid and Xiao'er Chiqiao Qingre Granules (Tonpei) continue to penetrate national chain and individual pharmacies, deepening cooperation with e-commerce platforms and continuously improving the convenience of patients' drug purchasing. In addition, Pudilan Xiaoyan Oral Liquid has been successfully converted to OTC status, allowing patients to purchase it directly at offline pharmacies and on online e-commerce platforms without a doctor's prescription, further enhancing drug accessibility. And to meet the differentiated medication needs of pediatric patients and improve patient experience, Xiao'er Chiqiao Qingre Syrup (K-tonpei) has been launched to enrich children's drug options and safeguard children's health.

 

Both Pudilan Xiaoyan Oral Liquid and Xiao'er Chiqiao Qingre Granules (Tonpei) earning the title of "2025–2026 Best-Selling Products in China's Pharmaceutical Retail Marke " is both an affirmation of the clinical and market value of these products and a high recognition of their brand building. As a well-known listed pharmaceutical company in China, JumpCan Pharmaceutical will continue to uphold the corporate purpose: build a joyful and vibrant life together, remain patient-centered, and develop more high-quality, strong-branded, high-loyalty products, ensuring that excellent products reach a wider population and safeguard public health.